 |
|
MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
Rex Wan-Hin Hui, Lung-Yi Mak
Clin Mol Hepatol. 2025;31(1):290-292. Published online 2024 Aug 7 DOI: https://doi.org/10.3350/cmh.2024.0630
|
|
Citations to this article as recorded by
 Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after vira
Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
Clinical and Molecular Hepatology.2025; 31(1): e64. CrossRef
|